Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients. (Q46794502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Jie Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yu-qian Bao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rong Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Cong-rong Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jun-xi Lu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Wei-ping Jia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kun-san Xiang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

Acta Pharmacologica Sinica

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

252-258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2008.00744.x

1 January 2020

exact match

0 references

cites work

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Sequence variation in PPARG may underlie differential response to troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

ABCA1: at the nexus of cholesterol, HDL and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

A note on exact tests of Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Pharmacogenetics and pharmacogenomics: development, science, and translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

The DREAM trial – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2008.00744.X

10.1111/J.1745-7254.2008.00744.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215356%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 January 2020

0 references

1 reference